Synthesis and control of process-related impurities in the β-lactamase inhibitor drug substance zidebactam

被引：1

作者：

Pund, Amit A. ^{[1
]}

Rane, Vipul P. ^{[1
]}

Raut, Vivek T. ^{[1
]}

Ahirrao, Vinod K. ^{[1
]}

Yeole, Ravindra D. ^{[1
]}

Joshi, Sanjeev ^{[1
]}

Bhavsar, Satish ^{[1
]}

Rafeeq, Mohammad ^{[1
]}

Yadav, Ramprasad ^{[1
]}

Merwade, Arvind Y. ^{[1
]}

机构：

[1] Wockhardt Res Ctr, MIDC, Chikalthana, D-4, Aurangabad, India

来源：

SYNTHETIC COMMUNICATIONS | 2023年 / 53卷 / 13期

关键词：

beta-lactamase inhibitor; impurities; stereoisomer; zidebactam;

D O I：

10.1080/00397911.2023.2209677

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Zidebactam is a novel extended spectrum beta-lactamase inhibitor (ESBLI). It's combination with cefepime (WCK 5222) is in phase III clinical studies. Five process impurities were found in zidebactam (1) drug substance using process development through reverse phase high performance liquid chromatography (HPLC) method. To give access to the reference standards for the impurity profile of the drug substance as well as the final product, these process impurities of compound 1, have been synthesized and characterized. [GRAPHICS] .

引用

页码：1041 / 1052

页数：12

共 50 条

[1] Identification, Synthesis, and Control of Process-Related Impurities in the Antipsychotic Drug Substance Brexpiprazole
Tyagi, Rahul
Singh, Harnam
Singh, Jagat
Arora, Himanshu
Yelmeli, Vijayalaxmi
Jain, Mohit
Girigani, Sathyanarayana
Kumar, Pramod
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (11) : 1471 - 1480
[2] Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin
Huang, Yiwen
He, Xiaoqing
Wu, Taizhi
Zhang, Fuli
MOLECULES, 2016, 21 (08)
[3] Strategies for the investigation and control of process-related impurities in drug substances
Argentine, Mark D.
Owens, Paul K.
Olsen, Bernard A.
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) : 12 - 28
[4] Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug
Dams, Iwona
Bialonska, Agata
Cmoch, Piotr
Krupa, Malgorzata
Pietraszek, Anita
Ostaszewska, Anna
Chodynski, Michal
MOLECULES, 2017, 22 (08)
[5] Synthesis and Characterization of Process-Related Impurities of Antihypertensive Drug Olmesartan Medoxomil
Venkanna, G.
Madhusudhan, G.
Mukkanti, K.
Sankar, A.
Kumar, Y. Sampath
Narayana, G. Venakata
JOURNAL OF CHEMISTRY, 2013, 2013
[6] Identification, synthesis and quantification of process-related impurities in auraptene
Li, Yan-Gang
Chen, Hai-Fang
Tu, Ming-Zhu
Zhang, Pu-Zhao
Wang, Xiao-Yun
Yuan, Jin-Bin
Yang, Wu-Liang
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 56 (02) : 191 - 199
[7] Identification and Synthesis of Process-Related Impurities in Lisdexamfetamine Dimesylate
Mandavkar, Sagar
Gole, Pradip
Pawar, Rushikesh
Deshmukh, Vishal
Kishore, D. V. P.
Bonde, Nilesh L.
Kotharkar, Sandeep A.
Joshi, Sunil V.
LETTERS IN ORGANIC CHEMISTRY, 2023, 20 (10) : 982 - 990
[8] Process-Related Impurities of Pazopanib
Terentjeva, Svetlana
Muceniece, Dzintra
Lusis, Viesturs
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2019, 23 (09) : 2057 - 2068
[9] Identification and synthesis of potential process-related impurities of trametinib: an anti-cancer drug
Saladi, J. S. Chakradhar
Nangi, Gangadhar Bhima Shankar
Chavakula, Ramadas
Karumanchi, Kishore
Bonige, Kishore Babu
CHEMICAL PAPERS, 2023, 77 (03) : 1759 - 1763
[10] Identification and synthesis of potential process-related impurities of trametinib: an anti-cancer drug
J. S. Chakradhar Saladi
Gangadhar Bhima Shankar Nangi
Ramadas Chavakula
Kishore Karumanchi
Kishore Babu Bonige
Chemical Papers, 2023, 77 : 1759 - 1763

← 1 2 3 4 5 →